A trial to investigate if aspirin reduces the risk of developing ovarian cancer in high risk women with abnormalities in their BRCA1 or BRCA2 gene (or both).

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2019
This article has no abstract
Epistemonikos ID: e90acd36b4623aa67c2b7325a1f14ad2c03c48c2
First added on: Aug 24, 2024